BioNTech lowers 2026 sales outlook as COVID vaccine demand softens
来源：Reuters发布于 2026-08-04
German vaccine maker BioNTech lowered its full year sales outlook range on Tuesday due to softer-than-expected COVID-19 vaccine demand and the timing of milestone-related revenues.
相关标的：BNTX
本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。